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tion of MRP2 expressed in epithelial cells depends uponThe session devoted to the cell biologic properties
the cells’ polarized state. Prior to the establishment ofof ABC transport proteins addressed the mechanisms
cell-cell contacts and the formation of fully differentiatedthrough which these polypeptides are synthesized, trans-
plasma membrane domains, MRP2 is retained in intra-ported through the cell and delivered to their sites of
cellular vesicular structures. Formation of a polarizedfunctional residence. Piet Borst (Amsterdam, The Nether-
monolayer is associated with the redistribution of MRP2lands) discussed the physiologic requirement for domain
from this intracellular compartment to the apical cellspecific localizations of multidrug resistance proteins
surface, suggesting that the surface expression of MRP2(MRP) in polarized epithelial cells. MRP1, -3 and -5 are
is dependent upon the acquisition by the apical domaindistributed predominantly at the basolateral surfaces in
of specific organized features. The group of Balazs Sar-the polarized epithelial cells in which they are endoge-
kadi has studied the sorting requirements of the basolat-nously expressed. In contrast, MRP2 behaves as an apical
eral MRP1. It is perhaps surprising that deletion of theplasma membrane protein. Efforts to identify the se-
first five transmembrane helices (the TMD domain) ofquence motifs that serve as the sorting signals that specify
these distinct distributions have been hampered by the MRP1 does not impede its delivery to the cell surface.
Furthermore, this truncated protein is delivered cor-difficulties inherent in obtaining high level stable expres-
sion of MRP constructs in polarized cell lines and by the rectly to the basolateral cell surface when expressed by
transfection in MDCK cells [2]. In contrast, removingstructural complexity of the MRP proteins themselves.
When the cDNA encoding MRP2 is transfected into a the L domain, which links the TMD to the core of MRP1,
results in a protein that is retained in the endoplasmicvariety of mammalian cell lines stable and clonal expres-
sion of the encoded protein is very difficult to achieve. reticulum (ER). Remarkably, expression of the MRP
core and the L domain as separate constructs results inThe best expression results are obtained with polarized
epithelial cells, including the Madin-Darby canine kid- the assembly of these two pieces and the appropriate
delivery of the resultant reconstituted protein to the ba-ney (MDCK) and the porcine LLC-PK1 lines of renal
epithelial cells [1]. Interestingly, the subcellular distribu- solateral membrane [3].
Summary: ABC cassette proteins 1515
Irwin Arias (Boston, Massachusetts, USA) discussed niques also were employed to monitor the localization
of the F508 protein in treated cells. Treatment withthe trafficking pathways pursued by ABC transport pro-
calcium pump inhibitors released ER-retained F508teins in hepatocytes [4]. The secretory pathway pursued
CFTR channels to the cell surface, where they functionedby most membrane proteins in hepatocytes leads first
effectively as Cl channels and mediated trans-epithelialto the sinusoidal plasma membrane domain. Proteins
ion secretion. Gene targeted mice homozygous for thedestined for delivery to the canalicular domain are inter-
F508 CFTR mutation were exposed to nebulized thap-nalized by endocytosis following the delivery to the si-
sigargin or DBHQ to determine whether these treat-nusoidal surface and carried by transcytosis to the canali-
ments could be effective in an in vivo model system.cular plasma membrane. ABC transport proteins do not
Mice were exposed to nebulized calcium pump inhibitorseem to follow this rather baroque scheme. The canalicu-
for three hours per day for seven days and then subjectedlar ABC transporters, including MDR1, MDR2 and
to measurement of the nasal epithelial potential differ-BSEP, never appear at the sinusoidal plasmalemma [5].
ence (NPD). While NPD in CF animals is markedlyInstead, they are either delivered directly from the Golgi
abnormal, NPD measurements recorded from drugcomplex to the canalicular membrane or to an intracellu-
treated CF animals were very similar to those measuredlar storage compartment. BSEP accumulates in an intra-
in wild-type controls. Mice tolerated daily drug treat-cellular storage compartment that is characterized by the
ment for up to 21 days without noticeable ill effect. Whilepresence of the endosomal marker rab11. Under resting
the mechanism through which treatment with calciumconditions, the bulk of the hepatocytes’ complement of
pump inhibitors elicits these effects have yet to be deter-BSEP protein is present in the intracellular compart-
mined, it appears that the drug treatment reverses thement. This intracellular pool of BSEP can be mobilized
interaction between the F508 protein and several chap-for delivery to the cell surface by elevation of cAMP or
erones, including calnexin, Hsp 90 and Hsc 70. Thus, ERthe addition of taurocholate [6]. There appear to be two
calcium pump inhibitors represent a new and potentiallyintracellular pools of BSEP, since the extent of mobiliza-
clinically applicable approach to ameliorating the CFtion achievable with cAMP and taurocholate is additive.
defect.The trafficking behaviors of ABC proteins in hepato-
cytes can be observed directly in real time by expressing
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